Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 976 AL 990

Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia

Mohajeri MH, Troesch B, Weber P.

Nutrition. 2015 Feb;31(2):261-75. doi: 10.1016/j.nut.2014.06.016. Epub 2014 Jul 24.

A review on Alzheimer's disease pathophysiology and its management: an update

Kumar A, Singh A, Ekavali.

Pharmacol Rep. 2015 Apr;67(2):195-203. doi: 10.1016/j.pharep.2014.09.004. Epub 2014 Sep 22.

CLU rs2279590 polymorphism contributes to Alzheimer's disease susceptibility in Caucasian and Asian populations

Zhang S, Zhang D, Jiang Y, Wu L, Shang H, Liu J, Feng R, Liao M, Zhang L, Liu Y, Liu G, Li K.

J Neural Transm (Vienna). 2015 Mar;122(3):433-9. doi: 10.1007/s00702-014-1260-9. Epub 2014 Jun 20.

Cardiovascular system participation in Alzheimer's disease pathogenesis

Roher AE.

J Intern Med. 2015 Apr;277(4):426-8. doi: 10.1111/joim.12311. Epub 2014 Oct 20.

Common Polymorphisms in the GSK3β Gene May Contribute to the Pathogenesis of Alzheimer Disease: A Meta-Analysis

Lin Q, Cao YP, Gao J.

J Geriatr Psychiatry Neurol. 2015 Jun;28(2):83-93. doi: 10.1177/0891988714554712. Epub 2014 Oct 27.

Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis

Wu S, Ding Y, Wu F, Li R, Hou J, Mao P.

Neurosci Biobehav Rev. 2015 Jan;48:1-9. doi: 10.1016/j.neubiorev.2014.11.008. Epub 2014 Nov 21.

The MTHFR C677T polymorphism contributes to increased risk of Alzheimer's disease: evidence based on 40 case-control studies

Peng Q, Lao X, Huang X, Qin X, Li S, Zeng Z.

Neurosci Lett. 2015 Jan 23;586:36-42. doi: 10.1016/j.neulet.2014.11.049. Epub 2014 Dec 5.

Re: Urinary incontinence in patients with Alzheimer's disease: relationship between symptom status and urodynamic diagnoses

Griebling TL.

J Urol. 2015 Mar;193(3):946-7. doi: 10.1016/j.juro.2014.12.071. Epub 2014 Dec 18.

CR1 in Alzheimer's disease

Zhu XC, Yu JT, Jiang T, Wang P, Cao L, Tan L.

Mol Neurobiol. 2015 Apr;51(2):753-65. doi: 10.1007/s12035-014-8723-8. Epub 2014 May 4.

Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis

Wang J, Yu JT, Wang HF, Meng XF, Wang C, Tan CC, Tan L.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):101-9. doi: 10.1136/jnnp-2014-308112. Epub 2014 May 29.

Neuropsychiatric symptoms of dementia: are pharmacological treatments effective and safe?

Ford AH.

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):4. doi: 10.1136/jnnp-2014-308420. Epub 2014 May 29.

An Updated Analysis with 85,939 Samples Confirms the Association Between CR1 rs6656401 Polymorphism and Alzheimer's Disease

Shen N, Chen B, Jiang Y, Feng R, Liao M, Zhang L, Li F, Ma G, Chen Z, Zhao B, Li K, Liu G.

Mol Neurobiol. 2015;51(3):1017-23. doi: 10.1007/s12035-014-8761-2. Epub 2014 May 31.

Does bilingualism contribute to cognitive reserve? Cognitive and neural perspectives

Guzmán-Vélez E, Tranel D.

Neuropsychology. 2015 Jan;29(1):139-50. doi: 10.1037/neu0000105. Epub 2014 Jun 16.

At the interface of sensory and motor dysfunctions and Alzheimer's disease

Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, Holtzer R, Hyman BT, Lin FR, McKee AC, Morris JC, Petersen RC, Silbert LC, Struble RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI.

Alzheimers Dement. 2015 Jan;11(1):70-98. doi: 10.1016/j.jalz.2014.04.514. Epub 2014 Jul 9.

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study

ADAPT-FS Research Group.

Alzheimers Dement. 2015 Feb;11(2):216-25.e1. doi: 10.1016/j.jalz.2014.03.009. Epub 2014 Jul 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias